Multivalent clostridial toxin derivatives and methods of their use
    2.
    发明申请
    Multivalent clostridial toxin derivatives and methods of their use 有权
    多价梭菌毒素衍生物及其使用方法

    公开(公告)号:US20060211619A1

    公开(公告)日:2006-09-21

    申请号:US11376696

    申请日:2006-03-15

    摘要: The present invention is directed to multivalent Clostridial neurotoxin derivatives having more than one binding domain directed to a cell surface feature of a target cell. Such modified neurotoxins are useful as therapeutic compositions to prevent exocytosis and secretion by the target cell. Conditions in which such compositions man be useful include, without limitation, disorders of the sensory or motor nervous system, acute or chronic pain, cancer, pancreatitis, hyperhydrosis, glandular disorders, viral infections, cystic fibrosis and the like. The invention is also directed to methods of using and administering such a composition, and methods of treating a given condition using such a composition.

    摘要翻译: 本发明涉及具有针对靶细胞的细胞表面特征的多于一个结合结构域的多价梭菌神经毒素衍生物。 这种修饰的神经毒素可用作预防目标细胞胞吐和分泌的治疗组合物。 这些组合物可用的条件包括但不限于感觉或运动神经系统的疾病,急性或慢性疼痛,癌症,胰腺炎,超氧化,腺体疾病,病毒感染,囊性纤维变性等。 本发明还涉及使用和施用这种组合物的方法,以及使用这种组合物治疗给定病症的方法。

    Leucine-based motif and Clostridial neurotoxins
    9.
    发明申请
    Leucine-based motif and Clostridial neurotoxins 有权
    亮氨酸为主题和梭菌神经毒素

    公开(公告)号:US20050276820A1

    公开(公告)日:2005-12-15

    申请号:US11039268

    申请日:2005-01-19

    摘要: Modified neurotoxin comprising neurotoxin including structural modification, wherein the structural modification alters the biological persistence, preferably the biological half-life, of the modified neurotoxin relative to an identical neurotoxin without the structural modification. The structural modification includes addition or deletion of a leucine-based motif or parts thereof. In one embodiment, methods of making the modified neurotoxin include using recombinant techniques. In another embodiment, methods of using the modified neurotoxin to treat biological disorders include treating autonomic disorders, neuromuscular disorders or pains.

    摘要翻译: 包含神经毒素的改性神经毒素包括结构修饰,其中所述结构修饰改变了修饰神经毒素相对于相同神经毒素的生物学持续性,优选生物半衰期而没有结构修饰。 结构修饰包括加入或缺失基于亮氨酸的基序或其部分。 在一个实施方案中,制备修饰的神经毒素的方法包括使用重组技术。 在另一个实施方案中,使用经修饰的神经毒素治疗生物学障碍的方法包括治疗自主神经障碍,神经肌肉疾病或疼痛。

    FRET PROTEASE ASSAYS FOR CLOSTRIDIAL TOXINS
    10.
    发明申请
    FRET PROTEASE ASSAYS FOR CLOSTRIDIAL TOXINS 审中-公开
    用于封闭性毒素的FRET蛋白质测定

    公开(公告)号:US20080038756A1

    公开(公告)日:2008-02-14

    申请号:US11780925

    申请日:2007-07-20

    IPC分类号: G01N33/569 C07K14/33 C12Q1/04

    摘要: The present invention provides clostridial toxin substrates useful in assaying for the protease activity of any clostridial toxin, including botulinum toxins of all serotypes as well as tetanus toxins. A clostridial toxin substrate of the invention contains a donor fluorophore; an acceptor having an absorbance spectrum overlapping the emission spectrum of the donor fluorophore; and a clostridial toxin recognition sequence that includes a cleavage site, where the cleavage site intervenes between the donor fluorophore and the acceptor and where, under the appropriate conditions, resonance energy transfer is exhibited between the donor fluorophore and the acceptor.

    摘要翻译: 本发明提供了可用于测定任何梭菌毒素(包括所有血清型的肉毒毒素)以及破伤风毒素的蛋白酶活性的梭菌毒素底物。 本发明的梭菌毒素底物含有供体荧光团; 具有与供体荧光团的发射光谱重叠的吸收光谱的受体; 和梭菌毒素识别序列,其包括切割位点,其中切割位点插入供体荧光团和受体之间,并且在适当条件下,在供体荧光团和受体之间显示共振能量转移。